Approval · Notice of Compliance 11660 · 2010
VIREAD: Notice of Compliance 11660
Issued August 12, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11660
- Date
- August 12, 2010
- Company
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised indication: Viread is indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents in patients 12 years of age and older
- Therapeutic class
- Antiretroviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VIREAD | Not yet assigned | — |
Medicinal ingredients
- TENOFOVIR DISOPROXIL FUMARATE 300 MG per TAB